Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?
- 1 August 1999
- journal article
- Published by Springer Nature in The Japanese Journal of Thoracic and Cardiovascular Surgery
- Vol. 47 (8) , 361-367
- https://doi.org/10.1007/bf03218027
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- First-Line Chemotherapy Improves the Resection Rate and Long-Term Survival of Locally Advanced (T4, any N, M0) Squamous Cell Carcinoma of the Thoracic EsophagusAnnals of Surgery, 1997
- Neoadjuvant therapy for oesophageal cancerBritish Journal of Surgery, 1997
- Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trialThe Journal of Thoracic and Cardiovascular Surgery, 1997
- A Randomized Trial of Isonitrogenous Enteral Diets After Severe TraumaAnnals of Surgery, 1996
- Early Enteral Feeding in Postsurgical Cancer PatientsAnnals of Surgery, 1996
- Mortality and Morbidity Rates, Postoperative Course, Quality of Life, and Prognosis After Extended Radical Lymphadenectomy for Esophageal GancerAnnals of Surgery, 1995
- Long-Term Results of Subtotal Esophagectomy with Three-Field Lymphadenectomy for Carcinoma of the Thoracic EsophagusAnnals of Surgery, 1994
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992
- Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagusThe Annals of Thoracic Surgery, 1988
- Selection of Operation for Esophageal Cancer Based on StagingAnnals of Surgery, 1986